Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.390EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.319EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.572EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.397EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.3 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.523EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.116 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.38 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.340EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.437EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.452EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.400EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.16 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.46.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.37 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.336EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.317EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.397EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.5.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CA.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ED.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDP.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used